Le Lézard
Classified in: Health
Subjects: LGB, AVO

The Trevor Project Applauds President Biden's Historic Pride Month Executive Order Supporting LGBTQ Youth


The executive order addresses many of the organization's top advocacy priorities, including working to end the dangerous and discredited practice of conversion therapy, expanding the collection of LGBTQ-inclusive data across the federal government, protecting transgender and nonbinary youth's access to gender-affirming care, and investing in suicide prevention and mental health resources in schools and for the launch of 988.

NEW YORK, June 15, 2022 /PRNewswire-PRWeb/ -- The Trevor Project, the world's largest suicide prevention and mental health organization for lesbian, gay, bisexual, transgender, queer & questioning (LGBTQ) young people, released the following statement in response to President Biden's signage of an "Executive Order Advancing Equality for LGBTQI+ Individuals."

Statement from Amit Paley (he/him pronouns), CEO & Executive Director of The Trevor Project:

"This historic executive order will advance long-sought, LGBTQ-inclusive policies and practices that will help save young LGBTQ lives. It's past time that we put an end to the dangerous and discredited practice of conversion 'therapy,' and expand access to the affirming care LGBTQ young people actually need to survive and thrive. It's crucial that our schools and the upcoming 988 lifeline are properly equipped with specialized suicide prevention resources for LGBTQ youth. And LGBTQ Americans deserve to be fully counted in federal data collection and afforded civil rights protections through the passage of the Equality Act.

"Thank you to President Biden for this comprehensive plan to protect LGBTQ youth, especially those who are transgender or nonbinary, people of color, experiencing homelessness, or in the foster care system. Despite recent and relentless political attacks, we are hopeful that this will move us forward toward a day where all LGBTQ young people can be themselves without fear of discrimination or violence."

Relevant research from The Trevor Project:

If you or someone you know needs help or support, The Trevor Project's trained crisis counselors are available 24/7 at 1-866-488-7386, via chat at TheTrevorProject.org/Get-Help, or by texting START to 678678.

About The Trevor Project
The Trevor Project is the world's largest suicide prevention and mental health organization for lesbian, gay, bisexual, transgender, queer & questioning (LGBTQ) young people. The Trevor Project offers a suite of 24/7 crisis intervention and suicide prevention programs, including TrevorLifeline, TrevorText and TrevorChat as well as the world's largest safe space social networking site for LGBTQ youth, TrevorSpace. Trevor also operates an education program with resources for youth-serving adults and organizations, an advocacy department fighting for pro-LGBTQ legislation and against anti-LGBTQ rhetoric/policy positions, and a research team to discover the most effective means to help young LGBTQ people in crisis and end suicide.

Media Contact

Rob Todaro, The Trevor Project, 212-695-8650, [email protected]

 

SOURCE The Trevor Project


These press releases may also interest you

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...



News published on and distributed by: